bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

7230 Articles (5723 medRxiv, 1507 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Modified SIR-model applied to covid-19, similarity solutions and projections to further development
Rebhan, E.
10.1101/2020.07.30.20165035 — Posted: 2020-08-03
A New Model of SARS-CoV-2 Infection Based on (Hydroxy)Chloroquine Activity
Sheaff, R. J.
10.1101/2020.08.02.232892 — Posted: 2020-08-02
A Systemic and Molecular Study of Subcellular Localization of SARS-CoV-2 Proteins
Zhang, J., Cruz-cosme, R., Zhuang, M.-W., Liu, D., Liu, Y., Teng, S., Wang, P.-H., Tang, Q.
10.1101/2020.08.02.233023 — Posted: 2020-08-02
Purification of recombinant SARS-CoV-2 spike, its receptor binding domain, and CR3022 mAb for serological assay
Tee, K. L., Jackson, P. J., Scarrott, J. M., Jaffe, S. R., Johnson, A. O., Johari, Y., Pohle, T. H., Mozzanino, T., Price, J., Grinham, J., Brown, A., Nicklin, M. J., James, D. C., Dickman, M. J., Wong, T. S.
10.1101/2020.07.31.231282 — Posted: 2020-08-02
Rapid Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Tungsten Trioxide-Based (WO3) Photocatalysis
Ghezzi, S., Pagani, I., Poli, G., Perboni, S., Vicenzi, E.
10.1101/2020.08.01.232199 — Posted: 2020-08-02
Impact of tocilizumab administration on mortality in severe COVID-19
Tsai, A., Diawara, O., Nahass, R. G., Brunetti, L.
10.1101/2020.07.30.20114959 — Posted: 2020-08-02
Clinical Utility of a Highly Sensitive Lateral Flow Immunoassay as determined by Titer Analysis for the Detection of anti-SARS-CoV-2 Antibodies at the Point-of-Care
Haymond, A., Mueller, C., Steinberg, H., Hodge, K. A., Lehman, C. W., Lin, S.-C., Collini, L., Branscome, H., Nguyen, T. V., Rucker, S., Panny, L., Flor, R., Guirguis, R., Hoefer, R., Lorenzin, G., Petricoin, E., Kashanchi, F., Kehn-Hall, K., Lanzafame, P., Liotta, L., Luchini, A.
10.1101/2020.07.30.20163824 — Posted: 2020-08-02
Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection
Desai, N., Neyaz, A., Szabolcs, A., Shih, A. R., Chen, J. H., Thapar, V., Nieman, L. T., Solovyov, A., Mehta, A., Lieb, D. J., Kulkarni, A. S., Jaicks, C., Pinto, C. J., Juric, D., Chebib, I., Colvin, R. B., Kim, A. Y., Monroe, R., Warren, S. E., Danaher, P., Reeves, J. W., Gong, J., Rueckert, E. H., Greenbaum, B. D., Hacohen, N., Lagana, S. M., Rivera, M. N., Sholl, L. M., Stone, J. R., Ting, D. T., Deshpande, V.
10.1101/2020.07.30.20165241 — Posted: 2020-08-02
Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories
Harritshoej, L. H., Gybel-Brask, M., Afzal, S., Kamstrup, P. R., Joergensen, C. S., Thomsen, M. K., Hilsted, L. M., Friis-Hansen, L. J., Szecsi, P. B., Pedersen, L., Nielsen, L., Hansen, C. B., Garred, P., Korsholm, T.-L., Mikkelsen, S., Nielsen, K. O., Moeller, B. K., Hansen, A. T., Iversen, K. K., Nielsen, P. B., Hasselbalch, R. B., Fogh, K., Norsk, J. B., Kristensen, J. H., Schoenning, K., Kirkby, N. S., Nielsen, A. C. Y., Landsy, L. H., Loftager, M., Holm, D. K., Nilsson, A. C., Saekmose, S. G., Grum-Svendsen, B., Aagaard, B., Jensen, T. G., Nielsen, D. M., Ullum, H., Dessau, R. B.
10.1101/2020.07.30.20165373 — Posted: 2020-08-02
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
Knight, S. R., Ho, A., Pius, R., Buchan, I., Carson, G., Drake, T. M., Dunning, J., Fairfield, C. J., Gamble, C., Green, C. A., Gupta, R. K., Halpin, S., Hardwick, H., Holden, K., Horby, P. W., Jackson, C., McLean, K. A., Merson, L., Nguyen-Van-Tam, J. S., Norman, L., Noursadeghi, M., Olliaro, P. L., Pritchard, M. G., Russell, C. D., Shaw, C. A., Sheikh, A., Solomon, T., Sudlow, C., Swann, O. V., Turtle, L., Openshaw, P. J., Baillie, J. K., Semple, M. G., Docherty, A. B., Harrison, E. M.
10.1101/2020.07.30.20165464 — Posted: 2020-08-02

RSS  Collection RSS | JSON

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).